Health Archive » March, 2012

Health - March, 2012

301 articles

• $100M CIGNA Sex Bias Suit Shut Down
• Blue Cross Michigan Dodges City's Price-Fixing Suit
• Calif. High Court To Mull Employer Arbitration Deals Again
• Judge Keeps Investor Suits Over Acadia-PHC Merger Alive
• Doctors Beg CMS For Relief From 'Storm' Of Regulations
• W.Va. Hospital Cos. Pay $2.25M Over FCA Medicaid Claims
• Detroit Clinic Owner Admits To $5.4M Medicare Fraud
• Amerigroup Will Pay $4.5M To Settle Sales Reps' OT Action
• Case Study: Hermelin V. KV Pharmaceutical
• Questioning The Enforcement Of Arbitration Provisions
• Medicare's Pay For Performance Didn't Cut Mortality: Study
• House Passes $3.5T Ryan Budget Plan
• Insurers Can't Shake General Refractories' Coverage Suit
• 3rd Circ. Boots Judge From West Penn Antitrust Case
• Ex-Temple Med School Official Gets 7 Years For Health Fraud
• Court Rules NY Medicaid Boost For Psychiatry Ended In '07
• Pharmacy Groups Sue Express Scripts, Medco Over $29B Deal
• FTC Says Pharmacy Antitrust Amnesty Will Hurt Competition
• Searching For Patent Drafting Pointers In Prometheus
• The Evolution Of Medicare ACOs
• States' Medicaid Coercion Argument Sways Some Justices
• 5 Hit With New Indictment In $14.5M Medicare Scam Case
• Judge Limits Claims In Quest Ageism Suit To NJ Workers
• Health Co. To Cough Up $7M To End Medicaid Fraud Claims
• $29B Express Scripts, Medco Merger Could Come Next Week
• Justices Divided On Power To Scrap Entire Health Care Law
• NY Dems Slam GOP For Holding Out Against Health Exchange
• Fla. Appeals Court Affirms $3.4M Award To Smoker's Widow
• FTC Orders ProMedica To Sell Ohio Hospital
• 11th Circ. Keeps Door Shut On Cigna Antitrust Claims
• FTC Says Mo. Bill Would Limit Pain Treatment Choices
• 3rd Circ. Seeks Ruling On Whether Health Dues Are Plan Assets
• Ratting Out The Competition: New DOJ Strategies
• Must-Have Performance Metrics For Law Departments
• High Court's Take On Health Market Key To ACA Decision
• Health Reform Poses Few New Litigation Risks, GAO Finds
• HIPAA Privacy Updates Head To White House For Final Review
• $45M Winning Bid For Bankrupt NJ Hospital OK'd
• Lawmakers Vow Health Law Repeal If High Court Lets It Stand
• TriWest Seeks To Wrest $20.5B DOD Contract From Rival
• $133B NY Budget To Boost Energy, Infrastructure Projects
• Humana Divests To Win DOJ Blessing For $150M Arcadian Buy
• Rapiscan Can't Shake X-Ray Distributor's $30M Contract Suit
• Costs Don't Have To Affect Medicaid Rates: Calif. Court
• Insurers V. Out-Of-Network Providers: An Ongoing Battle
• Hospital Group Says FCA Suit Is Light On False Claims
• 9th Circ. Keeps Calif. Medicaid Cuts Blocked
• High Court Health Reform Battle Focuses On Tax Law
• House Dems' Budget To Reinforce PPACA Medicare Coverage
• Chamber, Defense Attys Tell Supreme Court FLSA Suit Is Moot
• 11th Circ. Maintains Block On Aetna Antitrust Claims
• Court Finds For Attransco In $10M Asbestos Appeal
• $50M Worth Of Tobacco Appeals Won't Get High Court Hearing
• Protecting Patient Info In The Age Of Social Media
• A 'Shocking' Claim Of Design Defect
• Pharmaceutical Industry Trending Toward Self-Regulation
• Health Insurance Exchange Not In NY GOP's Senate Budget
• Medco Settles CalPERS Bribery Suit For $3M
• Philly Nurses Indicted In $14.3M Medicare Fraud Scheme
• States Enact Early Health Reforms As Tougher Terms Loom
• FTC Seeks High Court Scrutiny Of Ga. Hospital Merger
• Health Care Reform Faces Ultimate Test In High Court
• Fla. Oncologists Sued Over Alleged $3.5M Medicare Fraud
• Lawmaker Says Bill Would Shrink Medicare Part C Costs
• Cryobank Denied Coverage In Fighting Investor Fraud Claims
• LifeWatch Pays $18.5M To Settle DOJ Medicare Claims Suits
• Tax Benefits Biased Under DOMA, Calif. Employees Say
• PPACA: A Pandora's Box For The Health Care Industry
• DC Circ. Renews CVS Pharmacies' Controlled Drug Sales Ban
• Genzyme Tops Cobrek In Kidney Drug Patent Fight
• Judge Trims Mich. Nurses' Wage-Fixing Action
• UK Court Invalidates AstraZeneca's Seroquel XR Patent
• HHS Calls Out Two Insurers For 'Unreasonable' Rate Hikes
• Judge Trims Expert Testimony In Novartis Bone Drug Suit
• After Prometheus Loss, High Court Eyes Cancer Gene Patent
• High Court Asked To Reinstate $26M Merck Vioxx Judgment
• More Inspiration From The Courts On Commercial Speech
• Fed. Circ. Axes Sanofi IP Claims Over Genentech Cancer Drugs
• House Votes To Nix Medicare Cost-Cutting Board
• Husch Blackwell Picks Up Duane Morris Patent Pro
• Wash. Takes Emergency Contraceptives Ruling To 9th Circ.
• Sessions Blocks Vote To Air High Court Health Law Debate
• Cos. Must ID Supervisors Before Union Campaigns, Attys Say
• Stryker's Wingspan Stent May Raise Stroke Risk, FDA Says
• Community Health Escapes Tenet Medicare Billing Suit
• Justices' Questions May Signal Health Mandate's Fate
• Report Finds Medicaid Audit System Needs Overhaul
• Pharmacies Targeted In Probe Of Gray-Market Drug Sales
• Stakeholders To Weigh In On Making More Drugs OTC
• GOP Zeroes In On Agency Implementing Health Care Law
• Insurers Stuck In Asbestos Duty-To-Defend Suit
• Judge Tosses Calif. County's Vioxx Class Action
• Rising Star: Paul Weiss' Jacqui Rubin
• Fewer Life Sciences Co. Investor Suits Lodged In 2011
• DC Circ. Says ViroPharma Can't Sue FDA Over Generics Ruling
• GSK, J&J Back New $198.5M Incubator Fund
• Expanding The 'Quick Look' Framework
• Skowron To Pay Morgan Stanley $10.2M For Stock Dump
• Roche Urges Illumina Shareholders To Spur $6B Merger
• Canada Places Cancer Warnings On Merck And GSK Drugs
• Ala. Can't Claim Sovereign Immunity In Hiring Suit: 11th Circ.
• Battle Rages Over Home Health Workers' FLSA Status
• High Court Eyes Power of Federal Funds in Health Law Row
• Bill Nixing Health Law's Medicare Board Advances
• Dissecting Mayo V. Prometheus
• Waxman Pressures FTC On $29B Express Scripts, Medco Deal
• Rising Star: King & Spalding's Marian Lee
• TriWest Loses $20B Military Health Deal After Fraud Fine
• Pfizer To Pay Oregon $3.3M To End Zyvox Marketing Suit
• GOP's Budget Pushes For Medicare Voucher System
• Judge Tainted $60M Trademark Row, NuVasive Tells 9th Circ.
• OTC Drugmaker Says BioZone Breached Cold Meds Contract
• Case Study: Abbott Point Of Care V. Epocal
• Prometheus Blood Test Unpatentable, High Court Rules
• GSK Asks High Court To Buck DOL On Sales Reps' OT Status
• Mylan, Apotex Secure FDA Approval For Generic Boniva
• Rising Stars: Hunton & Williams' Colleen Heisey
• FDA Recalls Brilliant Blue G After Eye Infection Reports
• Mercer Consultant Pleads Guilty To Insider Trading
• Convicted NY Hospital Fraud Plotters Say DOJ Hid Witness
• Tax Code Ruling Could Leave Health Reform Law In Limbo
• Activists Push NY Senate On Health Insurance Exchange
• FTC Urged To Probe Merck, Sanofi Vaccine Bundling
• Challenging Providers: A Health Plan Flexes Its Muscle
• Judge Clears Feds For Withholding Generic Vancocin Docs
• Presenting ... A Fresh Interpretation Of Old Policy
• Blue Cross ERISA Class Rebuffed By High Court
• Covidien Shells Out $300M For Israeli Medical Device Maker
• Novartis Bone Drug Action Doomed By Statute Of Limitations
• Eisai Says Sanofi Misled Court In Feud Over Deposition Docs
• Obama Admin Floats Proposals On Contraception Rules
• Federal Plan To Share Health Insurance Risk Is Released
• Baxter Scores $24M Judgment In Fresenius Patent Suit
• GAO Denies TrailBlazer's $442M Medicare Bid Protest
• Schwarzenegger's Medicare Rule Opt-Out For Anesthetists OK'd
• Rising Star: Zuckerman's Marcos Hasbun
• DC Circ. Revives Cardinal Shipping Ban In Oxycodone Fight
• High Court Vows Same-Day Audio Of Health Care Debate
• Panel Recommends Standardized Medicare Treatment Fees
• Sens. Push For Stalled FDA Rule On Device ID System
• Genzyme Targets InvaGen Over Kidney Treatment Generics
• Learning From Blue Cross Data Breach Settlement
• Jury Rules In Favor Of Carl Zeiss In Lens Patent Suit
• Synthes, Stryker Settle Trade Secrets Suit Over Sales Reps
• Case Study: Bristol-Myers V. Kappos
• Sanofi Acquires Pluromed To Commercialize Surgical Gel
• Impax Can't Shake Injunction On Generic Amrix
• Bipartisanship Breaks Down Behind Medicare Board Repeal
• Intervening Rights Require Text Changes, Fed. Circ. Says
• GSK Strikes $613M Deal With Omega For OTC Brands, Plant
• NYC, Rudin Reach Deal On Greenwich Village Mixed-Use Project
• Sanofi Asks Fed. Circ. To Upset Dr. Reddy's Allegra Patent Win
• CBO Says 5M May Lose Employer Coverage Under Health Law
• CVS Caremark Says No Wrongdoing Alleged In FCA Suit
• Shire Inks $325M Deal For Blood Disorder Drug Co.
• Guidant Can't Kill $726M FCA Suit Over Implant Claims
• Biotech Co. Sues Sandoz Over Remodulin Generic
• Shire Pulls US Drug Application, Blames FDA Delay
• Albemarle Loses Bid To Toss EPA Clean Air Act Suit
• Trends In White Collar Crime Investigations, Prosecutions
• Judge Combines 2 Suits Over Egg Donor Price Caps
• Professor Seeks FDA Probe Into Stem Cell Cos.' Practices
• 3rd Circ. Grants Arbitration In Tenet Meal Break Case
• DaVita Unit Can't Sidestep Ex-Nurse's Medicaid Fraud Suit
• Faruqi Firm Won't Get Lead Role In Roche Takeover Action
• Microsoft Revises Privacy Policy To Reflect Targeted Health Ads
• DC Circ. Lifts CVS Pharmacies' Prescription Sale Ban
• Roche Loses Bid To Block Generic Boniva
• Teva Gets FDA Green Light For 1st Lexapro Generic
• 9th Circ. Seeks Amicus Briefs On Medicare Claim Appeals
• Hospital Asks 3rd Circ. To Drop Judge In Antitrust Row
• HHS Loosens Oversight Of Medicare Equipment Suppliers
• Judge Slashes Ex-Omeros Exec's FCA Suit Over NIH Grants
• Forest Labs Starts Patent Battle Over Beta-Blocker
• Pay For Delay, There For The Taking?
• The Uncertainty Of Medicaid Entitlement Enforcement
• Patient Broker Admits Role In $205M Medicare Bribery Scam
• UK Medical Journal Invokes Anti-SLAPP Law In Libel Suit
• FTC Seeks More Info From Roche On $6B Illumina Takeover
• Pfizer Won't Get To Trim BYU's Bextra-Celebrex Suit
• Boston Scientific Award Upped To $42M In Cordis Stent IP War
• DOJ Defends FOIA Response In Kagan Health Care Fight
• Tenn. Blue Cross To Hand Over $1.5M For Patient Data Breach
• University of Miami Says Medicaid FCA Suit Lacks Facts
• Roche Unit Loses In Arbitration Over Merger Of Medical Cos.
• Precision BioSciences Expands Patent War Against Cellectis
• DC Circ. Foils Bid To Ban Mercury-Containing Vaccines
• Texas Hospital Dodges $30M FCA Suit Over Drug Supplies
• Some Warner Chilcott Birth Control May Not Work, FDA Warns
• Cover Your Tail: Post-Termination Options For Docs
• AstraZeneca Sues FDA Over Generic Seroquel Labels
• Express Scripts, Medco Delay Deal Pending FTC Review
• Medtronic Investors Sue Over $3B Inflated Stock Buyback
• Injured Wal-Mart Workers Seek Approval Of $8M Settlement
• Sandoz, Others Escape Faulty Painkiller Patch Case
• HHS Issues Final, Flexible State Insurance Exchange Rule
• Japanese Health Giant Snaps Up Device Maker For $2.2B
• Bayer Must Allow Cancer Generic In India, Court Rules
• FDA To Review TV Drug Ads Before Broadcast
• Report Criticizes Cost Monitoring In DOD Health Program
• Judge Says Co. Can 'Fill Gap' To Trigger Excess Policy
• Calif. County Wants Claims Cut Loose From Plasma MDL
• GSK Skirts FCA Suit Over Physician Kickback Program
• J&J Unit's Stelara Infringes Abbott Patents, Judge Rules
• FTC Asks Pharm Groups How To Fix $29B Express Scripts Deal
• Why Communications Is Key To Merger And Lateral Success
• Drugmaker Bryan Corp. Sues Supplier Over Ingredient Quality
• FDA Moves To Improve Tracking Of Drug Safety Issues
• FDA Approves Third Silicone Gel Breast Implant
• FDA Rebuffs AstraZeneca's Bid To Delay Generic Seroquel
• Biotech Industry Sees Dollar Signs In Jobs Bill
• Lilly, Zydus Settle ADHD Generic Infringement Case
• Calif. Mulls Easing Abortion Law As Other States Set Limits
• Sens. Probe Role Of Rite Aid Wellness Ambassadors
• Azur, Avanir Push To Arbitrate $35M FazaClo Feud
• Maximus, Insurer Drop Claims Over $78M Texas Settlement
• Health Care Is Undergoing Major Surgery In 2012
• Ex-Partner Goes After Troutman In $520M Malpractice Suit
• GSK Seeks High Court Input On IP Safe-Harbor Rule
• Latham & Watkins Reps Boston Scientific In $1.3B Deal
• Tobacco Ads Spurred Minors To Smoke, Surgeon General Says
• Add-Ons To Drug User Fee Law Hit FDA Opposition
• Limbaugh Backlash Sparks Fight Over Concentra Name
• Blue Cross Cites Split Circuits In Antitrust Immunity Appeal
• Chadbourne Atty Can't Stop Apartment Roof Garden
• Health Groups Fight Delay Of Clear Insurance Explanations
• Final Committee OKs Nixing Health Law's Medicare Board
• Ill. Agencies Faulted Over $7B In Health Care Contracts
• Tackling 'Pay-For-Delay' In Calif. Supreme Court
• The Interplay Between FDA Approval And Discovery Rule
• AstraZeneca Sues Mylan Over Nexium Patents
• Judge Blocks Rival Botox Drug In Trade Secrets Trial
• Google Ordered To Dispense Canadian Pharmacy Ad Docs
• Investor Fights Illumina's Poison Pill Against Roche Bid
• Takeda Hid Diabetes Drug's Heart Risks, Ex-Reviewer Says
• Senate OKs Bill To Beef Up Counterfeit Drug Penalties
• NY Regulator Blasts Out-Of-Network Health Care Costs
• Pfizer, Others Sued By Health Plans Over Copay Coupons
• Medicare Pushes To Recruit Seniors In Fraud Fight
• Amgen Seeks High Court Review Of Investor Class Cert.
• Sens. Push Sebelius To Protect Medical Research Funds
• Boiron To Pay Up To $12M To End False Advertising Suits
• Enzo Targets Abbott, Others Over DNA Testing Patents
• The Dark Side Of The Power Wheelchair Revolution
• Tort Wars: The Calif. Legislature Strikes Back
• Espada Tax Charges Filed In Wrong District, Judge Says
• GOP Lawmakers Scrutinize Low-Cost Drug Program
• 11th Circ. Limits Contribution Claims Under CERCLA
• J&J Unit In Hot Seat Over Pfizer ThermaCare IP
• Lawmakers Demand Info On Agencies' Email Monitoring Rules
• Lorillard Owes $41M To Lung Cancer Widow, Jury Finds
• Medtronic Had Burden In Device IP Suit, Fed Circ. Told
• Reed Smith Guides Domain In $760M Venture With Rusnano
• Coventry, Policyholders Agree To $3.3M Deal Over Copays
• AeroShot Caffeine Inhaler Scrutinized By FDA
• Repeal Of Medicare Cost Board Zipping Along In House
• FDA Finds Multiple Quality Violations At Synthes Plant
• Texas Doc Denied Bail In Record Medicare Fraud Case
• Avanir Targets Watson In Suit Over Nuedexta Patents
• Premerger Plans Aren't Anti-Competitive: Calif. Court
• DC Circ. Lifts Shipping Ban On Cardinal Health
• Mensing Shields Generics Makers In Sprawling Darvocet MDL
• Immucor To Pay $22M To Stanch Blood Test Antitrust Action
• Doctors Bash Plan To Fight Rx Abuse By Denying Claims
• Zingers Fly As House Closes In On Medicare Board Repeal
• Ex-FDA Chemist Gets 5 Years For Insider Trading
• FDA Rejects Merck's Combo Cholesterol Drug For Now
• Judge Won't Halt NH Medicaid Cut Fight, Citing High Court
• Health Info Services Co. Jobson Gets OK On Prepack Ch. 11
• Novo Nordisk Faces $70M Sales Rep OT Action
• UK Biotech Co. Abcam Expands With $170M Epitomics Buy
• Calif. Council Merges 13 Cases Over Sutter Health Data Leak
• DaVita Can't Escape FCA Suit Over Kidney Med Charges
• NH Wins 1st Medicaid Boost For In-Home Senior Care
• Sunovion Knocks Out 5 Patents In Mylan's Brovana Suit
• Invisalign Maker Tells ITC Rival's Imports Infringe Patents
• Grassley Seeks Medicaid Managed Care Rate Setting Info
• Millennium Labs Wants Rival's Attys Booted For Misconduct
• Merck Action Didn't Stop The Clock, Va. High Court Says
• Law360 Life Sciences Editorial Advisory Board
• Law360 Health Editorial Advisory Board
• GOP Attacks $111B Jump In Health Reform Law Spending
• Perkins Coie Nabs Health Team For New Practice Group
• GSK Shakes EU Scrutiny In Generics Delay Probe
• How CMS Plans To Recoup Medicare, Medicaid Overpayments
• Odyssey Strikes $25M Deal Over Medicare Fraud Claims
• New NY Bankruptcy Chief Chides Attys In St. Vincent Case
• New Drug Co. Ethics Rules Focus On Doctor Relations
• Jury Sides With Pfizer Unit In Prempro Breast Cancer Case
• Relief Offer Annuls Nurse's Action, Genesis Tells High Court
• HHS' Sebelius Under Fire Over Contraception Rules
• FDA Warns Of 2 Hazardous Chemicals Used In Drugs
• Pfizer, Apotex End Patent Fight Over Generic Lipitor
• FDA Delays Approval Of Pfizer-BMS Anti-Clotting Drug
• Reglan Failure-To-Warn Suit Brought To Supreme Court
• Cardinal Health Painkiller Shipment Suspension Upheld
• Investor Objections Can't Halt Amgen's $1.2B Micromet Buy
• Senate Blocks Religious Exemption To Health Coverage
• Pfizer Asks High Court To Scrap Novartis Hemophilia Patents
• EU Kills Generics Delay Probe Of AstraZeneca, Nycomed
• NYC Hospital Pays $13M For Medicare Turbocharging